Safety and Efficacy Study of MT-2990 in Women With Endometriosis

  • STATUS
    Recruiting
  • End date
    Aug 26, 2021
  • participants needed
    76
  • sponsor
    Mitsubishi Tanabe Pharma Development America, Inc.
Updated on 28 February 2021
Investigator
Clinical Trials Information Desk, to prevent miscommunication,
Primary Contact
Continental Clinical Solutions (9.3 mi away) Contact
+50 other location

Summary

The purpose of this study is to assess the safety and efficacy of MT-2990 for treatment of moderate to severe endometriosis-related pain in women with surgically diagnosed endometriosis.

Details
Condition Endometrial Related Pain
Treatment Placebo, MT-2990
Clinical Study IdentifierNCT03840993
SponsorMitsubishi Tanabe Pharma Development America, Inc.
Last Modified on28 February 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note